Apogem Co-Investment VII, LP
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$300M
Investors
12
Min Invest
$1,000,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Apogem Co-Investment VII, LP is a Delaware limited partnership that first filed a Form D on April 8, 2021 and most recently amended it on July 26, 2023, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(7) and covers pooled investment fund interests. Apogem Co-Investment VII, LP reported $299,868,093 sold from 12 investors in an offering of indefinite size as of the Form D filed July 26, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $1,000,000. The Form D names NYLIFE Distributors LLC (CRD 35350), associated with None as the recipient of sales compensation soliciting in all states. The issuer's address of record is 299 Park Avenue, 37th Floor, New York, NY 10171.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing July 26, 2023
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2023-07-26: 5 related persons added and 8 removed against the filing of 2021-04-08; 5 now listed. The names are in the Terminal feed.
Richard Wiltshire
Executive Officer · NEW YORK, NY
Managing Director of Apogem Capital LLC, the Issuer's Investment Manager
Charles Cocuzza
Executive Officer · NEW YORK, NY
Managing Director of Apogem Capital LLC, the Issuer's Investment Manager
John Grady
Executive Officer · NEW YORK, NY
Chief Financial Officer of Apogem Capital LLC, the Issuer's Investment Manager
Christopher Stringer
Executive Officer · NEW YORK, NY
Managing Director and Head of Private Equity of Apogem Capital LLC, the Issuer's Investment Manager
Apogem Capital LLC
Promoter · NEW YORK, NY
Investment Manager
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
NYLIFE Distributors LLCCRD 35350 on BrokerCheck
Associated broker-dealer: None · Jersey City, NJ · Soliciting in all states
Questions About Apogem Co-Investment VII, LP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Apogem Co-Investment VII, LP?
Apogem Co-Investment VII, LP is a Delaware limited partnership that filed a Form D with the SEC on July 26, 2023 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of pooled investment fund interests.
Is Apogem Co-Investment VII, LP legit?
AltStreet does not rate legitimacy; it reports the public record. Apogem Co-Investment VII, LP filed a Form D with the SEC on July 26, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $299,868,093 sold to 12 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Apogem Co-Investment VII, LP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Apogem Co-Investment VII, LP claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Apogem Co-Investment VII, LP raised?
Apogem Co-Investment VII, LP reported $299,868,093 sold from 12 investors in an offering of indefinite size as of the Form D filed July 26, 2023.
Who can invest in Apogem Co-Investment VII, LP?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $1,000,000.
What is the minimum investment in Apogem Co-Investment VII, LP?
The Form D lists $1,000,000 as the minimum investment accepted from any outside investor as of July 26, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Apogem Co-Investment VII, LP and how are they paid?
The Form D names NYLIFE Distributors LLC (CRD 35350), associated with None as the recipient of sales compensation soliciting in all states.
Who is behind Apogem Co-Investment VII, LP?
The Form D lists 5 related persons: Richard Wiltshire, executive officer (Managing Director of Apogem Capital LLC, the Issuer's Investment Manager); Charles Cocuzza, executive officer (Managing Director of Apogem Capital LLC, the Issuer's Investment Manager); John Grady, executive officer (Chief Financial Officer of Apogem Capital LLC, the Issuer's Investment Manager); Christopher Stringer, executive officer (Managing Director and Head of Private Equity of Apogem Capital LLC, the Issuer's Investment Manager); Apogem Capital LLC, promoter (Investment Manager). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Apogem Co-Investment VII, LP located?
The issuer's address on its SEC filings is 299 Park Avenue, 37th Floor, New York, NY 10171. Its phone number of record is (212) 601-3600. It is organized under the laws of Delaware.
How long is the Apogem Co-Investment VII, LP offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is Apogem Co-Investment VII, LP?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.